These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 16679526

  • 1. Molecular dynamics simulations applied to the study of subtypes of HIV-1 protease common to Brazil, Africa, and Asia.
    Batista PR, Wilter A, Durham EH, Pascutti PG.
    Cell Biochem Biophys; 2006; 44(3):395-404. PubMed ID: 16679526
    [Abstract] [Full Text] [Related]

  • 2. Protease inhibition in African subtypes of HIV-1.
    Velázquez-Campoy A, Vega S, Fleming E, Bacha U, Sayed Y, Dirr HW, Freire E.
    AIDS Rev; 2003; 5(3):165-71. PubMed ID: 14598565
    [Abstract] [Full Text] [Related]

  • 3. Understanding the HIV-1 protease nelfinavir resistance mutation D30N in subtypes B and C through molecular dynamics simulations.
    Soares RO, Batista PR, Costa MG, Dardenne LE, Pascutti PG, Soares MA.
    J Mol Graph Model; 2010 Sep; 29(2):137-47. PubMed ID: 20541446
    [Abstract] [Full Text] [Related]

  • 4. Molecular dynamic and free energy studies of primary resistance mutations in HIV-1 protease-ritonavir complexes.
    Aruksakunwong O, Wolschann P, Hannongbua S, Sompornpisut P.
    J Chem Inf Model; 2006 Sep; 46(5):2085-92. PubMed ID: 16995739
    [Abstract] [Full Text] [Related]

  • 5. Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes.
    Velazquez-Campoy A, Vega S, Freire E.
    Biochemistry; 2002 Jul 09; 41(27):8613-9. PubMed ID: 12093278
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM-PBSA and thermodynamic integration study.
    Leonis G, Steinbrecher T, Papadopoulos MG.
    J Chem Inf Model; 2013 Aug 26; 53(8):2141-53. PubMed ID: 23834142
    [Abstract] [Full Text] [Related]

  • 12. Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism.
    Calazans A, Brindeiro R, Brindeiro P, Verli H, Arruda MB, Gonzalez LM, Guimaraes JA, Diaz RS, Antunes OA, Tanuri A.
    J Infect Dis; 2005 Jun 01; 191(11):1961-70. PubMed ID: 15871131
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach.
    Jenwitheesuk E, Samudrala R.
    Antivir Ther; 2005 Jun 01; 10(1):157-66. PubMed ID: 15751773
    [Abstract] [Full Text] [Related]

  • 15. Structural insights into the South African HIV-1 subtype C protease: impact of hinge region dynamics and flap flexibility in drug resistance.
    Naicker P, Achilonu I, Fanucchi S, Fernandes M, Ibrahim MA, Dirr HW, Soliman ME, Sayed Y.
    J Biomol Struct Dyn; 2013 Dec 01; 31(12):1370-80. PubMed ID: 23140382
    [Abstract] [Full Text] [Related]

  • 16. Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants.
    Kozísek M, Bray J, Rezácová P, Sasková K, Brynda J, Pokorná J, Mammano F, Rulísek L, Konvalinka J.
    J Mol Biol; 2007 Dec 07; 374(4):1005-16. PubMed ID: 17977555
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of commercial inhibitors against subtype F HIV-1 protease.
    Krauchenco S, Martins NH, Sanches M, Polikarpov I.
    J Enzyme Inhib Med Chem; 2009 Jun 07; 24(3):638-45. PubMed ID: 18825538
    [Abstract] [Full Text] [Related]

  • 18. Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates.
    Gonzalez LM, Santos AF, Abecasis AB, Van Laethem K, Soares EA, Deforche K, Tanuri A, Camacho R, Vandamme AM, Soares MA.
    J Antimicrob Chemother; 2008 Jun 07; 61(6):1201-4. PubMed ID: 18356151
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.